Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694366,Abfw8,Abdominal fat weight QTL 8,6.38,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),18,49130920,88201929,Rat,n/a,region,qtl 1000,1598826,Anxrr20,Anxiety related response QTL 20,3.04,,body movement coordination trait (VT:0005424),number of rearing movements in an experimental apparatus (CMO:0001752),18,46319476,88201929,Rat,n/a,region,qtl 1000,1331741,Bp232,Blood pressure QTL 232,3.59112,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),18,22603736,87074531,Rat,n/a,region,qtl 1000,1331733,Bp233,Blood pressure QTL 233,3.97196,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),18,25961026,81761656,Rat,n/a,region,qtl 1000,6903356,Bp354,Blood pressure QTL 354,4.6,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),18,61985648,88201929,Rat,n/a,region,qtl 1000,1578661,Bss20,Bone structure and strength QTL 20,3.7,,femur morphology trait (VT:0000559),femoral neck cross-sectional area (CMO:0001697),18,15695872,87080053,Rat,n/a,region,qtl 1000,1578667,Bss21,Bone structure and strength QTL 21,3.5,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),18,15695872,87080053,Rat,n/a,region,qtl 1000,6893359,Bw103,Body weight QTL 103,1.2,0.12,body mass (VT:0001259),body weight (CMO:0000012),18,57448678,88201929,Rat,n/a,region,qtl 1000,6893368,Bw107,Body weight QTL 107,0.3,0.5,body mass (VT:0001259),body weight (CMO:0000012),18,57448678,88201929,Rat,n/a,region,qtl 1000,631518,Bw11,Body weight QTL 11,2.8,,body mass (VT:0001259),body weight (CMO:0000012),18,38221919,83221919,Rat,n/a,region,qtl 1000,6893683,Bw110,Body weight QTL 110,2.7,0.002,body mass (VT:0001259),body weight (CMO:0000012),18,45002194,88201929,Rat,n/a,region,qtl 1000,8694432,Bw165,Body weight QTL 165,3.81,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),18,49130920,88201929,Rat,n/a,region,qtl 1000,1558649,Bw58,Body weight QTL 58,3.4,0.0005,body mass (VT:0001259),body weight (CMO:0000012),18,57448678,88201929,Rat,n/a,region,qtl 1000,2303571,Bw92,Body weight QTL 92,3,,body mass (VT:0001259),body weight (CMO:0000012),18,51375816,88201929,Rat,n/a,region,qtl 1000,1298072,Cia26,Collagen induced arthritis QTL 26,3.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),18,58196300,88201929,Rat,n/a,region,qtl 1000,9589041,Epfw12,Epididymal fat weight QTL 12,17.08,0.001,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),18,49130920,88201929,Rat,n/a,region,qtl 1000,2303584,Gluco55,Glucose level QTL 55,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),18,51375816,88201929,Rat,n/a,region,qtl 1000,738008,Hcar14,Hepatocarcinoma resistance QTL 14,4.3,,liver integrity trait (VT:0010547),liver nonremodeling tumorous lesion number (CMO:0001462),18,53033494,87080053,Rat,n/a,region,qtl 1000,61367,Iddm4,Insulin dependent diabetes mellitus QTL 4,2.33,0.0074,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),18,40375769,85375769,Rat,n/a,region,qtl 1000,724542,Kidm2,Kidney mass QTL 2,2.6,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),18,63009812,88201929,Rat,n/a,region,qtl 1000,1600373,Mamtr6,Mammary tumor resistance QTL 6,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),18,20285758,87080053,Rat,n/a,region,qtl 1000,2303120,Mamtr8,Mammary tumor resistance QTL 8,,0.001,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),18,32670352,87080053,Rat,n/a,region,qtl 1000,634333,Pia19,Pristane induced arthritis QTL 19,3.4,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),18,77151301,83366399,Rat,n/a,region,qtl